In an adult with acute renal colic, which is preferred: diclofenac or celecoxib?

Diclofenac is Superior to Celecoxib for Acute Renal Colic

For acute renal colic in adults, diclofenac is the preferred NSAID over celecoxib. The most recent European Association of Urology guidelines (2025) specifically recommend diclofenac (along with ibuprofen and metamizole) as first-line treatment for renal colic, while celecoxib is notably absent from these recommendations 1.

Evidence-Based Rationale

Guideline Recommendations

The 2025 EAU guidelines explicitly state that NSAIDs (diclofenac, ibuprofen, metamizole) are the first-line treatment for renal colic 1. This strong recommendation is based on evidence showing NSAIDs reduce the need for additional analgesia compared to opioids. Celecoxib is not mentioned as a recommended agent in these guidelines.

Direct Comparative Evidence

The most compelling evidence against celecoxib comes from a 2009 randomized controlled trial that directly tested celecoxib for renal colic 2. This study found:

• No difference in spontaneous stone passage rates (celecoxib 55.2% vs placebo 54.2%)
• No reduction in pain scores (2.6 vs 3.5, P = 0.71)
• No decrease in narcotic requirements (13.2 vs 13.6 doses, P = 0.74)

The authors concluded that celecoxib does not facilitate stone passage or decrease narcotic requirements in patients with acute renal colic 2.

Diclofenac's Proven Efficacy

Multiple meta-analyses demonstrate diclofenac's superiority:

• A 2017 systematic review found diclofenac was superior to other NSAIDs for pain relief (MD -12.57,95% CI: -19.26 to -5.88) 3
• A 2019 network meta-analysis identified diclofenac via intramuscular route as the recommended first-line agent for renal colic 4
• A 2026 randomized trial confirmed diclofenac provides superior rapid pain relief with a 70.9% pain relief rate at 30 minutes 5

Clinical Application Algorithm

Use diclofenac as first-line unless contraindicated:

1. Standard patient with adequate renal function and no cardiovascular disease:

   • Diclofenac 75 mg IM (preferred route per meta-analysis) 4
   • Alternative: Diclofenac 50 mg PO if IM not feasible

2. Patient with cardiovascular risk factors:

   • Still use diclofenac but consider lower dose
   • Note: While celecoxib has a better cardiovascular profile than some NSAIDs 6, it lacks efficacy for renal colic 2
   • If NSAID contraindicated entirely, use opioids as second-line 1

3. Patient with reduced GFR:

   • NSAIDs may impact renal function in patients with low GFR 1
   • Check creatinine before prescribing 7
   • Consider opioid alternatives if GFR significantly impaired

Important Caveats

Do not use celecoxib for renal colic - it has been specifically studied and found ineffective 2. The fact that it's a COX-2 selective NSAID does not translate to efficacy in this condition, unlike other pain syndromes.

Cardiovascular and gastrointestinal risks apply to all NSAIDs - use the lowest effective dose 1. However, diclofenac's proven efficacy for renal colic outweighs theoretical advantages of celecoxib's selectivity, especially since celecoxib doesn't work for this indication.

Route matters - intramuscular diclofenac has the most robust evidence base 4, 5, though IV ketorolac and IV ibuprofen are also effective alternatives 4, 8.

The evidence strongly favors diclofenac over celecoxib based on both guideline recommendations and direct comparative trials showing celecoxib's lack of efficacy in renal colic.